Covid: Omicron surge could differ per country, says WHO

A top World Health Organisation official says low hospitalisation and death rates in South Africa due to the omicron variant cannot be considered a template for other countries

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

AP | PTI  |  Geneva 

Photo: Bloomberg
Photo: Bloomberg

A top World Health Organisation official says low hospitalisation and death rates in South Africa due to the omicron variant cannot be considered a template for how the variant will fare as it surges in other countries.

Dr. Abdi Mahamud, COVID-19 incident manager at the U.N. health agency, notes a decoupling between case counts and deaths in the country, which first announced the emergence of the fast-spreading new variant.

He said Tuesday that in terms of hospitalisations South Africa remains "very low, and the death has remained very, very low.

But Mahamud says it cannot be extrapolated from South Africa to other countries, because each is country is unique on its own.

By its latest count, WHO says 128 countries had confirmed cases of the new variant that first emerged in southern Africa in November, but many other places which may not have complete testing capabilities are believed to have it too.

Mahamud notes that omicron has shown nearly unprecedented transmissibility for a virus.

He notes a remarkable increase in cases in the United States, where we are seeing more and more hospitalisations coming along. But he did cite an increasing number of studies showing omicron affects the upper part of the body, whereas other versions devastated lung function and caused severe pneumonia that led to many deaths.

Mahamud says that could be good news but that more studies are needed to get a full picture.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Tue, January 04 2022. 20:57 IST
RECOMMENDED FOR YOU